Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16885530rdf:typepubmed:Citationlld:pubmed
pubmed-article:16885530lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:16885530lifeskim:mentionsumls-concept:C0032005lld:lifeskim
pubmed-article:16885530lifeskim:mentionsumls-concept:C0021463lld:lifeskim
pubmed-article:16885530lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:16885530lifeskim:mentionsumls-concept:C0050668lld:lifeskim
pubmed-article:16885530lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:16885530lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:16885530pubmed:issue2lld:pubmed
pubmed-article:16885530pubmed:dateCreated2006-8-3lld:pubmed
pubmed-article:16885530pubmed:abstractTextActivins, as members of the transforming growth factor-beta superfamily, control and orchestrate many physiological processes and are vital for the development, growth and functional integrity of most tissues, including the pituitary. Activins produced by pituitary cells work in conjunction with central, peripheral, and other local factors to influence the function of gonadotropes and maintain a normal reproductive axis. Follistatin, also produced by the pituitary, acts as a local buffer to bind activin and modulate its bioactivity. On the other hand, inhibins of gonadal origin provide an endocrine feedback signal to antagonize activin signaling in cells that express the inhibin co-receptor, betaglycan, such as gonadotropes. This review highlights the pituitary roles of activin and the mechanisms through which these actions are modulated by inhibin and follistatin.lld:pubmed
pubmed-article:16885530pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:languageenglld:pubmed
pubmed-article:16885530pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:citationSubsetIMlld:pubmed
pubmed-article:16885530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16885530pubmed:statusMEDLINElld:pubmed
pubmed-article:16885530pubmed:monthAuglld:pubmed
pubmed-article:16885530pubmed:issn1470-1626lld:pubmed
pubmed-article:16885530pubmed:authorpubmed-author:ValeWylie WWWlld:pubmed
pubmed-article:16885530pubmed:authorpubmed-author:BilezikjianLo...lld:pubmed
pubmed-article:16885530pubmed:authorpubmed-author:BlountAmy LALlld:pubmed
pubmed-article:16885530pubmed:authorpubmed-author:DonaldsonCind...lld:pubmed
pubmed-article:16885530pubmed:issnTypePrintlld:pubmed
pubmed-article:16885530pubmed:volume132lld:pubmed
pubmed-article:16885530pubmed:ownerNLMlld:pubmed
pubmed-article:16885530pubmed:authorsCompleteYlld:pubmed
pubmed-article:16885530pubmed:pagination207-15lld:pubmed
pubmed-article:16885530pubmed:dateRevised2010-12-17lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:meshHeadingpubmed-meshheading:16885530...lld:pubmed
pubmed-article:16885530pubmed:year2006lld:pubmed
pubmed-article:16885530pubmed:articleTitlePituitary actions of ligands of the TGF-beta family: activins and inhibins.lld:pubmed
pubmed-article:16885530pubmed:affiliationThe Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, California 92037, USA. bilezikjian@salk.edulld:pubmed
pubmed-article:16885530pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16885530pubmed:publicationTypeReviewlld:pubmed
pubmed-article:16885530pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16885530pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16885530lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16885530lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16885530lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16885530lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16885530lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16885530lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16885530lld:pubmed